Fall COVID Vaccination: New Costs, Restrictions, and Updates
The FDA has narrowed approval for Covid-19 boosters to high-risk groups and seniors, potentially making vaccines more expensive and less accessible for others, with costs around $225 at retail pharmacies. This shift aligns with WHO recommendations but raises concerns about coverage and access, especially under the current administration led by RFK Jr., who has taken a skeptical stance on vaccines. Insurance coverage decisions will vary, and access may be hindered by legal and regulatory hurdles, amid rising Covid cases and political controversy.
